Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: lined (747)

Cyclophosphamide-Epirubicin-Paclitaxel 21day

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXEL Regimen • Breast Cancer – Cyclophosphamide-Epirubicin-Paclitaxel Indication • Neoadjuvant / adjuvant therapy of early breast cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Epirubicin-Paclitaxel-21day.pdf

InP-Cisplatin-Etoposide-Ifosfamide (VIP)

Description: Chemotherapy Protocol GERM CELL CISPLATIN-ETOPOSIDE-IFOSFAMIDE (VIP) Inpatient Regimen Regimen • Germ Cell – InP-Cisplatin-Etoposide-Ifosfamide (VIP) Indication • Metastatic Germ
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Cisplatin-Etoposide-Ifosfamide-VIP.pdf

First seizure - patient information

Description: This leaflet contains important information about having a seizure for the first time.
Url: /Media/UHS-website-2019/Patientinformation/Brain-and-spine/First-seizure-1641-PIL.pdf

Bevacizumab(15mgkg) Carboplatin Gemcitabine (day1)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1) This protocol may require funding Regimen • Ovary-Bevacizumab (15)-Carboplatin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg-Carboplatin-Gemcitabine-day1.pdf

Papers Trust Board 27 May 2021

Description: Date Time Location Chair Agenda Trust Board – Open Session 27/05/2021 9:00 - 13:00 Microsoft Teams Peter Hollins 1
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2021-Trust-document/TB-papers/Papers-Trust-Board-27-May-2021.pdf

Carboplatin-Vinorelbine Oral

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN (AUC6)-VINORELBINE (Oral) Regimen  NSCLC – Carboplatin (AUC6)-Vinorelbine (Oral) Indication  First line
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Vinorelbine-Oral.pdf

Carboplatin (AUC5)-Pegylated Liposomal Doxorubicin (Caelyx)x)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5) - DOXORUBICIN PEGYLATED LIPOSOMAL (Caelyx) Please note this protocol is based on information for the use
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Pegylated-Liposomal-DoxorubicinCaelyxVer1.pdf

Carboplatin(AUC6)-Pemetrexed

Description: Chemotherapy Protocol MESOTHELIOMA CARBOPLATIN (AUC6)-PEMETREXED Regimen • Mesothelioma – Carboplatin (AUC6)-Pemetrexed Indication • First line therapy of advanced pleural mesothelioma where the
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Mesothelioma/CarboplatinAUC6-Pemetrexed-Ver1.5.pdf

Carboplatin and Pemetrexed

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN-PEMETREXED Regimen • NSCLC – Carboplatin-Pemetrexed Indication • First line therapy of stage IIIB
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Pemetrexed-Ver1.4.pdf

Carboplatin(AUC5)Etoposide

Description: Regimen Chemotherapy Protocol BRAIN TUMOURS CARBOPLATIN (AUC5)-ETOPOSIDE • Brain – Carboplatin (AUC5)-Etoposide Indication • Third line treatment of glioblastoma multiforme • WHO Performance
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/CarboplatinAUC5-Etoposide.pdf

311 to 320 of 587

Previous … 30 31 32 33 34 … Next